Effectiveness of Trastuzumab (HerceptinTM) in a Patient with Locally Recurrent Breast Cancer after Cardiac Failure Caused by Severe Cytotoxic Pretreatment

Publisher： Karger

E-ISSN： 1423-0232|61|4|271-274

ISSN： 0030-2414

Source： Oncology, Vol.61, Iss.4, 2001-11, pp. : 271-274

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Trastuzumab Single-Drug Therapy after Failure of Cytotoxic Treatment for Metastatic Breast Cancer

By  

Oncology Research and Treatment, Vol. 33, Iss. 8-9, 2010-07 ,pp. : 425-430

Karger

Access to resources Recommend Favorite

Safety and Efficacy of Trastuzumab Every 3 Weeks Combined with Cytotoxic Chemotherapy in Patients with HER2-Positive Recurrent Breast Cancer: Findings from a Case Series

By  

Oncology Research and Treatment, Vol. 28, Iss. 11, 2005-10 ,pp. : 558-564

Karger

Access to resources Recommend Favorite

Weekly Paclitaxel (Taxol®) with or without Trastuzumab (Herceptin®) in Advanced Breast Cancer: A Community-Based Observation Study

By  

Oncology Research and Treatment, Vol. 26, Iss. 2, 2003-05 ,pp. : 128-132

Karger

Access to resources Recommend Favorite

Efficient and Safe Application of a FOLFIRI/Bevacizumab Combination to a Patient with Locally Advanced Rectal Cancer and Severe Chronic Renal Failure

By  

Oncology Research and Treatment, Vol. 30, Iss. 1-2, 2007-01 ,pp. : 65-65

Karger

Access to resources Recommend Favorite

Weekly Paclitaxel Combined with Local Hyperthermia in the Therapy of Breast Cancer Locally Recurrent after Mastectomy – a Pilot Experience

By  

Oncology Research and Treatment, Vol. 27, Iss. 4, 2004-09 ,pp. : 385-388

Karger

Access to resources Recommend Favorite